Most-used outcome measurements in clinical trials from 2018 to 2019 for plaque psoriasis

被引：0
|
作者：
Kamrani, Payvand [1 ]
Bashyam, Arjun [2 ]
Feldman, Steven [2 ]
机构：
[1] Wake Forest Sch Med, Dept Dermatol, Winston Salem, NC 27101 USA
[2] Wake Forest Sch Med, Winston Salem, NC 27101 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2020年 / 83卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
17638
引用
收藏
页码：AB196 / AB196
页数：1
相关论文
共 50 条
  • [21] Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials
    Michael Sticherling
    Arjen F. Nikkels
    Ashraf M. Hamza
    Pearl Kwong
    Jacek C. Szepietowski
    Mahira El Sayed
    Pierre-Dominique Ghislain
    Alkes A. Khotko
    Manmath Patekar
    Christine-Elke Ortmann
    Pascal Forrer
    Philemon Papanastasiou
    Deborah Keefe
    [J]. American Journal of Clinical Dermatology, 2023, 24 : 821 - 835
  • [22] Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials
    Sticherling, Michael
    Nikkels, Arjen F.
    Hamza, Ashraf M.
    Kwong, Pearl
    Szepietowski, Jacek C.
    El Sayed, Mahira
    Ghislain, Pierre-Dominique
    Khotko, Alkes A.
    Patekar, Manmath
    Ortmann, Christine-Elke
    Forrer, Pascal
    Papanastasiou, Philemon
    Keefe, Deborah
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (05) : 821 - 835
  • [23] Safety of extended and long-term efalizumab therapy for plaque psoriasis: Results from phase III clinical trials
    Carey, W
    Menter, A
    Leonardi, C
    Lynde, C
    Ouellet, J
    Toth, D
    Rosoph, L
    Papp, K
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 123 (02)
  • [24] Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents
    Vibeke Strand
    Joao Gonçalves
    Timothy P. Hickling
    Heather E. Jones
    Lisa Marshall
    John D. Isaacs
    [J]. BioDrugs, 2020, 34 : 27 - 37
  • [25] Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents
    Strand, Vibeke
    Goncalves, Joao
    Hickling, Timothy P.
    Jones, Heather E.
    Marshall, Lisa
    Isaacs, John D.
    [J]. BIODRUGS, 2020, 34 (01) : 27 - 37
  • [26] Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis
    Gordon, K. B.
    Lebwohl, M.
    Papp, K. A.
    Bachelez, H.
    Wu, J. J.
    Langley, R. G.
    Blauvelt, A.
    Kaplan, B.
    Shah, M.
    Zhao, Y.
    Sinvhal, R.
    Reich, K.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (03) : 466 - 475
  • [27] Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials
    Genovese, Mark C.
    Mysler, Eduardo
    Tomita, Tetsuya
    Papp, Kim A.
    Salvarani, Carlo
    Schwartzman, Sergio
    Gallo, Gaia
    Patel, Himanshu
    Lisse, Jeffrey R.
    Kronbergs, Andris
    Leage, Soyi Liu
    Adams, David H.
    Xu, Wen
    Marzo-Ortega, Helena
    Lebwohl, Mark G.
    [J]. RHEUMATOLOGY, 2020, 59 (12) : 3834 - 3844
  • [28] Psoriasis: talking points from recent clinical trials
    Chiricozzi, Andrea
    Bellinato, Francesco
    Romita, Paolo
    Gisondi, Paolo
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (12) : 1265 - 1267
  • [29] Long-term clinical trials of biologics in plaque psoriasis demonstrate heterogeneous study designs
    Grolleau, Chloe
    Le Cleach, Laurence
    Shourick, Jason
    Sbidian, Emilie
    Afach, Sivem
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (05) : 677 - 678
  • [30] Outcome Measurements Used in Randomized Controlled Trials of Teledermatology: A Systematic Mapping Review
    Chow, Aloysius
    Soon, Charlene
    Smith, Helen Elizabeth
    Apfelbacher, Christian J.
    [J]. ACTA DERMATO-VENEREOLOGICA, 2019, 99 (13) : 1210 - 1217
12345